In this issue:
Vitamin D deficiency impacts clinical outcomes in HL
Long-term follow-up of patients with nodular lymphocyte-predominant HL
Persistent mediastinal FDG uptake on PET-CT after frontline therapy
Outcomes in patients diagnosed with HL during pregnancy
PD-1 blockade as bridge to allogeneic stem cell transplantation in RRcHL
Nivolumab versus BV for RRcHL after failure of ASCT
Outcomes and toxicity of bleomycin use
Great prognosis for early stage cHL patients treated with ABVD and limited field radiotherapy
Brentuximab vedotin for RRcHL post-ASCT
Please login below to download this issue (PDF)